While we all sit here and wait another month for prurisol data, maybe we could look back at previous potential catalysts- you know, the short-lived catalysts that have failed to keep CTIX out of the dollar and change OTC area of the market
My favorite, as you all know, is the disappearing spleen lesion PR, where the share price climbed to nearly 5 on a report from one patient. Perhaps newbies would like to review some of those areas also, as we wait for actual share moving news
Do not worry about other non events such as P3B and P2 K ovarian trials -finally actually starting. And don't hold your breath for the really big other future non-event, the phase 1 K paper.
With B-OM(? half a year) and P(30 days or so) we will get actual news.
I thought we would hear something about B-OM with the B-UP announcement but that has come and gone. There is though still the excitement of guessing which country the B-UP trial is in